BrainHealth is dedicated to providing science-based programs and support to individuals at risk or in the early stages of Alzheimer's or other forms of cognitive impairment. Our primary objective is to enhance the cognitive prospects of millions of people, enabling them to lead longer, happier, and healthier lives.
Established in 2010, our parent company, NeuroVision, is comprised of experts in neurology, high-complexity fluid biomarkers, and diagnostic medical devices. We have established research collaboration agreements with 24 leading medical institutions and five pharmaceutical companies, and our Scientific Advisory Board consists of global leaders in the field, including Dr. Miia Kivipelto, who was lead researcher on the notable Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGERS). Our BrainHealth program is developed based this groundbreaking study, which demonstrated that adopting healthy lifestyle changes can measurably contribute to the prevention of cognitive decline.